AstraZeneca said Monday that late stage trials of its COVID-19 vaccine developed with Oxford University were “highly effective” in preventing disease.

The coronavirus vaccine developed by the University of Oxford stops 70% of people developing Covid symptoms, a large scale trial shows, reports BBC.